Abaxis management shuffle
This article was originally published in The Gray Sheet
Executive Summary
Firm names President and CEO Clint Severson as chairman of the board, replacing Abaxis co-founder Gary Stroy. Severson has been key to increasing revenue while reducing operational costs for the past seven quarters, the company says. Jim Canfield, former VP-marketing and sales at competitor Idexx Laboratories, joins Abaxis as VP-domestic marketing. Canfield replaces Vladimir Ostoich, who returns to his original position as VP-engineering. Chief Financial Officer and VP-finance Ting Lu is stepping down at the end of the month and will be replaced in the interim by Controller Reba Witwer. Other new appointments include Robert Milder as VP-operations; Larry Reynolds (VP-marketing and sales, Pacific Rim and Latin America) and Diane Oates (VP-regulatory affairs/quality systems)...
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.